Literature DB >> 8324078

A standardized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples.

S Lagoo-Deenadayalan1, A S Lagoo, W H Barber, K J Hardy.   

Abstract

A simple, rapid, reproducible, and nonradioisotopic method for semiquantitative analysis of cytokine mRNAs based on polymerase chain reaction (PCR) is described. RNA isolated from 2.5 million cells has proven sufficient to perform semiquantitative analysis of mRNA for 10 different cytokines. By this approach accurate assessment of mRNA levels for multiple cytokines can be made from as little as 2 ml of blood or about 3 mg of biopsy material. Total cellular RNA is quantitatively recovered by guanidinium isothiocyanate-acid-phenol extraction of a constant number of cells. Further quantitation of RNA is unnecessary. Highly reproducible PCR product formation occurs after specific amplification of aliquots of reverse transcribed test RNA. The photographic image of the ethidium bromide-stained gel accurately reflects the amount of PCR product loaded, both densitometrically and visually. PCR product generation is not affected by the presence of carrier RNA. Thus quantitative recovery of total RNA is possible even from a very small number of cells. Similarly, presence of a large excess of nonspecific RNA from nonexpressing cells does not affect amplification of the specific mRNA under study. A linear relationship between mRNA frequency and PCR product formation is observed over a 256- to 512-fold range. The actual mRNA concentration for each cytokine varies depending on the relative abundance of mRNA for that cytokine relative to total RNA. By performing two amplification cycles (28 and 35) on undiluted and 10-fold diluted RNA samples, the range of detection linearity is extended over a 5000-fold difference in input RNA levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324078

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  6 in total

1.  Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages.

Authors:  Xiaochuan Wang; Cheryl Allen; Mark Ballow
Journal:  J Clin Immunol       Date:  2007-01-26       Impact factor: 8.317

2.  Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models.

Authors:  J L Powell; A C Wright; S S Wasserman; D M Hone; J G Morris
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system.

Authors:  Misato Hashizume; Naohiko Hayakawa; Miho Suzuki; Masahiko Mihara
Journal:  Rheumatol Int       Date:  2009-03-07       Impact factor: 2.631

4.  Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.

Authors:  G Maass; W Schmidt; M Berger; F Schilcher; F Koszik; A Schneeberger; G Stingl; M L Birnstiel; T Schweighoffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

5.  Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses.

Authors:  R Glas; L Franksson; C Une; M L Eloranta; C Ohlén; A Orn; K Kärre
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

6.  Reduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-alpha stimulated human umbilical vein endothelial cells.

Authors:  Chaur-Jong Hu; Yueh-Lun Lee; Neng-Yao Shih; Yi-Yuan Yang; Suparat Charoenfuprasert; Yu-Shan Dai; Su-Mei Chang; Yu-Hui Tsai; How Tseng; Chia-Yu Liu; Sy-Jye Leu
Journal:  J Biomed Biotechnol       Date:  2010-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.